Scouting report · GOOGL

Anat Ashkenazi

Alphabet CFO since July 2024; Eli Lilly CFO 2021-2024

Born / age
(53)
Role
Senior Vice President, Chief Financial Officer, Alphabet and Google
In the role
2 yr
Education
BA The Hebrew University
Front Office rank
not ranked yet
GOOGL
Alphabet Inc.Megacap tech
Title
Senior Vice President, Chief Financial Officer, Alphabet and Googlesrc
In role
since 2024-07 (2 yr)
Stake value—no holding or price on file
—thin record

Scouting sheetas of 24 Sep 2026

Delivers guidance—no promises on the record yet
Answers the question—no call reviewed yet
Capital allocation—company not reviewed yet
Pay design87relative tsr, time only · 81.06% for · 0.02% of net income
Skin in the game—no holding or price on file
—Hit rate
—Pay at risk
81%Say-on-pay
—Airtime on calls
Beat
0
Met
0
Missed
0
Withdrawn
0
Still open
0
Answers on calls
0
Questions dodged
0
Dodges / 100 answers
—

Personal and ownership data

Full name
Anat Ashkenazi
Age
53src
Education
BA Economics and business administration, The Hebrew Universitysrc

Not on file yet: born, place of birth, citizenship, marital status.

Shares held
140,506 GOOGL, 2026-09-14src
Traded, 12 months
bought $0, sold $0src
Last pay
$31.3m 2025src
Say-on-pay vote
81.06% forsrc
CEO pay ratio
35 : 1

What to weigh

Watch 3

  • 2024 pay was $50.0m, mostly the one-time sign-on cash and make-whole equity for forfeited Lilly awards. 2025 pay was $31.3msrc
  • About two-thirds of her annual equity target is time-vested GSUs: $20m GSU against $10m PSU for 2026, plus a $6m transitional GSU. The PSUs pay only on TSR relative to the S&P 100src
  • Say-on-pay passed with 81.06% of votes cast for and against in June 2026, a count that includes the founders' 10-vote Class B sharessrc

In their favour 2

  • No open-market sales in the last 12 months. Vested Class C shares are held, with only tax withholding on vesting, and her direct Class C holding grew from 90,771 (2025-09-25) to 140,506 sharessrc
  • Met Alphabet's $7.5m SVP share-ownership requirement by 2025-12-31, per the proxy's statement that all NEOs complied. Hedging and pledging are prohibitedsrc

Pay

Salary and otherBonus, stock, options, incentive

  • $7.6m2023
  • $50.0m2024
  • $31.3m2025
The table
YearSalaryBonusStockOptionsIncentiveOtherTotal
2023$1.0m$0$3.7m$0$1.9m$1.0m$7.6msrc
2024$423k$9.9m$38.5m$0$850k$282k$50.0msrc
2025$1.0m$0$30.2m$0$0$84k$31.3msrc
Bonus pays on
No annual bonus: the SVP Bonus program was discontinued 2025-02-28 and its $2.0m target moved into PSUs. Salary $1.0m
Long-term award pays on
GSUs vesting over three years (plus a transitional top-up in 2025 and 2026) and PSUs on Alphabet's TSR relative to the S&P 100 over three years, 0-200% of target. 2026 targets: $20m GSU and $10m PSUsrc
  • Pay at risk not on file
  • Pays on returns relative tsr, time only
  • Shareholder vote 81.06% for
  • Pay vs profit 0.02% of net income

CEO pay ratio 35 : 1

Career

  1. 2024 – now
    Alphabet Inc. and Google LLCsrc
    Senior Vice President, Chief Financial Officer
    Announced 2024-06-05 and effective 2024-07-31. She succeeded Ruth Porat, who is now President & Chief Investment Officer
  2. 2021 – 2024
    Eli Lilly and Companysrc
    Chief Financial Officer (elected SVP & CFO 2021-02-09; EVP & CFO by 2023)
    Resigned effective July 2024 for a role outside the pharmaceutical industry (LLY-8K-2024)
  3. 2016 – 2021
    Eli Lilly and Companysrc
    Senior Vice President, Controller and CFO of Lilly Research Laboratories
    Oversaw the CFOs of the commercial businesses (BioMedicine, Diabetes, Oncology, International), R&D, manufacturing and quality, G&A, and accounting and financial reporting; also led corporate strategic planning and the business transformation office (LLY-8K-2021)
  4. 2001 – 2016
    Eli Lilly and Companysrc
    Finance, strategy and Six Sigma roles: CFO of Lilly Oncology; VP Finance and CFO of Lilly Diabetes and of Global Manufacturing & Quality
    Dates of the individual divisional CFO roles not stated

Undated in the sources

  • Ma'alot Standard & Poor's; Bank Hapoalim (Israel)src, Financial services

Not located: Dates of the pre-2016 Lilly divisional roles and of the pre-2001 Israeli roles are not stated in any source searched

The promise ledger

No promise on the record yet: the research routine has not scored this company's guidance.

Background

  • Family The 2026 proxy states there are no family relationships among any directors or executive officerssrc
  • Other Lilly promoted her to CFO in February 2021 when her predecessor left after an investigation into inappropriate personal communications. Lilly said his conduct did not concern financial controls or statementssrc
  • Other Lilly's June 2024 notice said she resigned to pursue an opportunity outside the pharmaceutical industry and would serve at full capacity through July 2024src
  • Other Her Alphabet offer paid a one-time $9.9m cash sign-on bonus and a $13.1m sign-on GSU grant to replace Lilly pay she forfeited. It also set a $1.0m salary and a discretionary bonus of up to 200% of salary, which was later discontinuedsrc
  • Other Early career in Israeli financial services at Ma'alot Standard & Poor's and Bank Hapoalim before joining Lilly in 2001src

Sources13